πŸ‡ΊπŸ‡Έ FDA
Patent

US 8563022

Particles for cell targeting

granted A61KA61K47/6923A61K47/6929

Quick answer

US patent 8563022 (Particles for cell targeting) held by The Board of Regents of the University of Texas System expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K47/6923, A61K47/6929, A61K49/0002, A61K9/143